Testosterone MDL Judge Denies Late Limitations Defenses In 1st Bellwether Case
CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on May 22 struck defendant AbbVie Inc.’s motion for summary judgment in the first bellwether trial after ruling...To view the full article, register now.
Already a subscriber? Click here to view full article